scholarly journals Co-Administration of GSK's AS04 Adjuvanted Cervical Cancer Vaccine with Combined dTpa-IPV Vaccine in Girls Aged 10–18 Years

2008 ◽  
Vol 12 ◽  
pp. e150 ◽  
Author(s):  
T.F. Schwarz ◽  
J. Garcia-Sicilia ◽  
A. Carmona ◽  
J.E. Malkin ◽  
M.P. Tran ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Vaccine ◽  
Cervical Cancer Vaccine

scholarly journals Cervical cancer vaccine development

Sexual Health ◽  
2010 ◽  
Vol 7 (3) ◽  
pp. 230 ◽  
Author(s):  
Ian H. Frazer
Keyword(s):  
Cervical Cancer ◽  
Clinical Trials ◽  
Human Papillomavirus ◽  
Cancer Vaccine ◽  
Vaccine Development ◽  
Global Burden ◽  
Viral Capsids ◽  
Cervical Epithelium ◽  
Papillomavirus Vaccines ◽  
Cervical Cancer Vaccine

Cervical cancer is initiated by infection of cervical epithelium with human papillomavirus. Vaccines have been developed, incorporating papillomavirus viral capsids and alum based adjuvants. In extensive clinical trials these vaccines have been shown safe and effective in preventing infection with, and disease caused by, the papillomavirus genotypes they incorporate, in women not already infected. These vaccines have the potential to reduce the global burden of cervical cancer by up to 70%.

scholarly journals Immunoinformatics Study on Early 4 Protein of Human Papillomavirus Type 16 for Cervical Cancer Vaccine Peptide Candidate

2019 ◽  
Vol 4 (2) ◽  
pp. 252-262
Author(s):  
Yani Suryani ◽  
Opik Taupiqurrohman ◽  
Muhammad Yusuf ◽  
Toto Subroto ◽  
Sukma Nuswantara
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Amino Acid ◽  
Cancer Vaccine ◽  
Vaccine Candidate ◽  
Peptide Vaccine ◽  
Human Papillomavirus Type 16 ◽  
Cervical Cancer Vaccine ◽  
Peptide Candidate

 The aims of this study were to carry out testing of the early 4 protein of type 16 HPV through immunoinformatics meth-ods in an effort to get the peptide vaccine candidate for cervical cancer. The software used are IEDB-AR, CABSdock and Accelrys Discovery Study 4.5. Based on the analysis that sequence of ami-no acid lysine, leucine, leucine, glycine, serine, threonine, tryp-tophan, proline and threonine (KLLGSTWPT) and the sequence of amino acid tyrosine, tyrosine, valine, leucine, histidine, leucine, cysteine, leucine, alanine, alanine, threonine, lysine, tyrosine, pro-line and leucine (YYVLHLCLAATKYPL) are peptide vaccine can-didate for cervical cancer from the early 4 protein of HPV type 16 

Feature

2008 ◽  
Vol 12 (10) ◽  
pp. 20-57
Keyword(s):  
Cervical Cancer ◽  
Cancer Research ◽  
Molecular Biology ◽  
Liver Transplant ◽  
Cancer Vaccine ◽  
Cancer Center ◽  
Max Planck ◽  
Dreaded Disease ◽  
Cervical Cancer Vaccine ◽  
Research Director

Taking One for the Girls – Meina Lee tells APBN why boys might want to consider taking the cervical cancer vaccine. Catching Cancer Early By Dr Achim Plum. APBN speaks with Dr Axel Ullrich, research director of the Singapore OncoGenome Project at A*STAR's Institute of Medical Biology and director of Molecular Biology at the Max Planck Institute of Biochemistry, who sheds more light on the cancer challenges ahead. APBN speaks to Professor Soo Khee Chee, director of National Cancer Center, about the much dreaded disease. APBN chats with Dr Susan Lim, who is widely known in Asia and Singapore for being the first surgeon to have performed a successful liver transplant. Cancer Research in Asia Pacifc by Serene Ong.

Sign in / Sign up

Export Citation Format

Share Document